Skip to main content
logo
Racura Oncology Ltd (ASX:RAC)
Australia flag Australia · Delayed Price · Currency is AUD
2.020
-0.010 (-0.49%)
Sep 17, 2026, 4:10 PM AEST

Racura Oncology Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
396434204311200311
Market Cap Growth
26.60%112.66%-34.32%55.59%-35.78%-41.00%
Enterprise Value
362413185297173274
Last Close Price
2.022.221.181.821.231.95

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
140.90154.4438.8577.6363.73439.48
PB Ratio
10.8711.9112.7516.977.848.62
P/TBV Ratio
11.5812.7015.1420.058.929.50

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
128.70146.9935.2874.2155.32387.06

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Debt / Equity Ratio
-0.94-0.94-0.85-0.94-0.84-0.93
Net Debt / EBITDA Ratio
3.393.392.621.212.113.07
Net Debt / FCF Ratio
4.164.162.991.802.025.36
Asset Turnover
0.100.100.280.170.100.03
Quick Ratio
21.2821.289.429.2620.1623.71
Current Ratio
21.4321.4310.299.3220.4424.10
Return on Equity (ROE)
-42.27%-42.27%-27.89%-63.10%-32.22%-44.96%
Return on Assets (ROA)
-23.40%-23.40%-18.24%-38.63%-20.41%-27.05%
Return on Capital Employed (ROCE)
-28.50%-28.50%-34.30%-78.90%-41.10%-31.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-2.80%-2.55%-2.34%-4.45%-4.97%-3.60%
FCF Yield
-2.08%-1.90%-2.24%-3.07%-5.33%-2.01%
Buyback Yield / Dilution
-3.90%-3.90%-4.81%-2.35%-4.83%-17.06%